7th Pharmacovigilance 2014

Top Quote Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management. 21st November 2014, Kohinoor Continental Hotel, Mumbai, India. End Quote
  • (1888PressRelease) November 21, 2014 - Get more from the event, with a broader scope bringing the whole communications value chain together.

    Key Themes Discussed at this Summit:
    - Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
    - Identifying the latest regulatory framework for pharmacovigilance
    - Crisis management within drug safety
    - Impact of technology - learn and explore
    - Explaining how to use the data sources and observational research for effective safety analysis
    - Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
    - Stay ahead of computing and electronic communications in pharmacovigilance
    - Risk management plans
    - Risk/benefit determinations
    - Implications for safety reporting in global clinical trials
    - Compliance and drug safety
    - Training for drug safety - reporting duties, audits and expectations - risk based inspections
    - Safety reporting in licensing agreement
    - Good supply chain management practices for medicine distribution
    - Accelerating new medicine introduction in developing world & overcoming challenges
    - Analyzing the information on current industry projects and trends
    - How will PV activities change with clinical trial transformation initiative?
    - Recent successful strategies and business models to bring out new medicines
    - Exploiting the pharmacy automations and technologies for enhancement of medication safety
    - Determining the steps and strategies for enhancing quality in healthcare
    - Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions.

    Key Speakers:
    - Mazhar Maruf, Head of Pharmacovigilance, Glenmar
    - Karthik Babu, Affiliate Pharmacovigilance Head, Sanofi
    - Abhay Chimankar, Head - Global Drug Safety, Cipla
    - Rahul Chauhan, Associate Director - Regulatory Affairs & Pharmacovigilance, Eli Lilly
    - Abhay Phansalkar, Head - Medical Affairs, Wockhardt
    - Bhaswat Chakraborty, Senior Vice President, Cadila
    - Babita Kirodian, Head of Country Pharmacovigilance, Bristol Myers Squibb
    - Manish Verma, Director Medical Affairs, Sanofi
    - Indu Nambiar, Clinical Safety Officer, Boehringer Ingelheim
    - Amit Arora, Head Medical Affairs, Merck Serono
    - Manish Shah, General Manager, Global Clinical Operations, Wockhardt
    - V K Sharma, Associate Vice President, Unichem Laboratories
    - Girish Parhate, Senior Manager - Regulatory Affairs, Bayer
    - Kamlesh Patel, GM, Medical Affairs & Pharmacovigilance, Abbott
    - Milind Antani, Head - Pharma LifeSciences, Nishith Desai Associates
    - Vandana Jolad Shivangi, Director, VIaTAL Pharma Consulting.
    Plus Many More...

    Target Audiance-Industry:-
    - Pharmaceutical organisations
    - Generic pharmaceutical companies
    - Contract research organisations
    - Patient recruitment companies
    - Government- Department of health
    - Non-profit organisations/ Association
    - Consultans.

    Who Should Attend:-
    Vice Presidents, Directors, CRO's, Heads and Managers of:
    - Pharmacovigilance Strategy
    - Drug Safety/Risk Management
    - Information and Clinical Data Management
    - Clinical Research
    - Research & Development
    - Product Safety/Assurance Assessment
    - Patient Safety & Outcomes Research & Data Analysis
    - Epidemiology project management
    - Regulatory Affairs and Compliance
    - Sales & Marketing
    - Biotech manufacturers.

    Why Should You Attend:
    Enjoy and make the best out of our dedicated networking drinks time,meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

    Conference Booking Details:

    Early Bird Discounted Price - Conference Delegate Pass (INR 6,000 + Tax (12.36%) per delegate) - Book and Pay before 07th October 2014 to avail the early bird discounted price. You can simply email or call and book your conference delegate seats on TEL: + 91 7401150416. Email - nisha ( @ ) virtueinsight dot co dot in dot

    Standard Price after early bird discounted time - 1 or 2 Delegates (INR 7,000 + Tax (12.36%) per delegate) - You can simply email or call and book your conference delegate seats on TEL: + 91 7401150416. Email - nisha ( @ ) virtueinsight dot co dot in dot

    Group Discounts - 3 or 4 Delegates - (INR 6,500 + Tax (12.36%) per delegate)

    Group Discounts - 5 and above Delegates - (INR 5,000 + Tax (12.36%) per delegate)

    Spot Registration on the day of the conference - 1 Day Conference - (INR 8,000 + Tax (12.36%) per delegate)

    Conference Sponsor & Exhibition Stall - Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to -TEL: + 91 7401150416. Email - nisha ( @ ) virtueinsight dot co.in.

  • FB Icon Twitter Icon In-Icon
Contact Information